Maintenance

Tomorrow I start another round of rituximab as a maintenance dose.  In some ways it seems a little weird, in the end it just makes sense.  It isn't because we know it is still there, it is because we know that we don't really know, and in b-cell lymphoma when it is used as a follow up round or several maintenance rounds, the number of complete remissions following the second round is really good.  Luckily the insurance approved it, a little later than scheduled, but without a fight.  So tomorrow and the following 3 Fridays I will be back in the chair in the infusion room.